The largest database of trusted experimental protocols

Q tof 6530 mass spectrometer

Manufactured by Agilent Technologies
Sourced in Germany, United States

The Agilent Q-TOF 6530 is a high-resolution mass spectrometer designed for accurate mass measurements and structural analysis. It uses quadrupole time-of-flight (Q-TOF) technology to provide precise mass data for molecular identification and characterization.

Automatically generated - may contain errors

19 protocols using q tof 6530 mass spectrometer

1

Fluorescence-based USP30 Deubiquitinase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescence intensity measurements were used to monitor the cleavage of a Ub–rhodamine (Ub-Rho110) substrate. All activity assays were performed in black 384-well plates in 20 mM Tris–HCl, pH 8.0, 150 mM potassium glutamate, 0.1 mM Tris(2-carboxyethyl)phosphine) (TCEP), and 0.03% bovine gamma globulin with a final assay volume of 20 μl. Compound IC50 values for DUB inhibition were determined as previously described (18 ). Briefly, an 11-point dilution series of compounds were dispensed into black 384-well plates using an Echo-550 Acoustic Liquid Handler (Beckman Coulter). USP30, 0.2 nM (residues 64–502Δ179–216 & 288–305; Viva Biotech [Shanghai] Ltd), was added, and the plates were preincubated for 30 min, 25 nM Ub-Rho110 (Ubiquigent) was added to initiate the reaction, and the fluorescence intensity was recorded for 30 min on a PHERAstar FSXEx = 485 nm, λEm = 520 nm) (BMG Labtech). Initial rates were plotted against compound concentration to determine IC50. Data were processed using analysis tools from Dotmatics (https://www.dotmatics.com/). RapidFire MS coupled to an Agilent QTof 6530 mass spectrometer (30 (link)) was used to confirm USP30 complex formation with USP30inh and assess cleavage of K6-linked di-Ub chains from USP30 in the presence and absence of the compound.
+ Open protocol
+ Expand
2

Quantification of Sphingolipid Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceramide and sphingomyelin concentrations were quantified by rapid resolution liquid chromatography/mass spectrometry. Short lipids were extracted from colon biopsies with C17-ceramide and C16-d31sphingomyelin as internal standards, after homogenization of colonic tissue. Subsequently, samples were analyzed by rapid-resolution liquid chromatography-MS/MS using a Q-TOF 6530 mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in the positive ESI mode. The subsequent quantification was performed using Mass Hunter Software, and the resulting sphingolipid quantities were normalized to the actual protein content of the homogenate.
+ Open protocol
+ Expand
3

Direct Infusion Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were analyzed by direct infusion on a QExactive mass spectrometer (Thermo Scientific) equipped with a TriVersa NanoMate ion source (Advion Biosciences). Samples were analyzed in both positive and negative ion modes with a resolution of R(m/z = 200) = 280,000 for MS and R(m/z = 200) = 17,500 for MSMS experiments, in a single acquisition. MSMS was triggered by an inclusion list encompassing corresponding MS mass ranges scanned in 1 Da increments (Surma et al., 2015 (link)). Both MS and MSMS data were combined to monitor CE, DAG, and TAG ions as ammonium adducts; PC, PC O-, as acetate adducts; and CL, PA, PE, PE O-, PG, PI, and PS as deprotonated anions. MS only was used to monitor LPA, LPE, LPE O-, LPI, and LPS as deprotonated anions; Cer, HexCer, SM, LPC, and LPC O- as acetate adducts. Additional Cer and SM analyses (University of Potsdam) were carried out with a 1260 Infinity LC system coupled to a QTOF 6530 mass spectrometer (Agilent Technologies) operating in the positive electrospray ionization mode (ESI+). The precursor ions of Cer or SM species (differing in their fatty acid chain lengths) were cleaved into the fragment ions m/z 264.270 or m/z 184.074, respectively (Kachler et al., 2017 (link)).
+ Open protocol
+ Expand
4

Targeted Mass Spectrometry for DCF and GCA

Check if the same lab product or an alternative is used in the 5 most similar protocols
DCF clearance and GCA were measured by targeted mass spectrometry on the Agilent QTOF instrument. Data were processed using Agilent MassHunter qualitative analysis software (version B.06). Peak areas of DCF (m/z 296.0245), 13C6-DCF, GCA (m/z 466.3169), and d5-GCA as internal standard were obtained using the extracted ion chromatogram (EIC) function. MS/MS spectra of DCF metabolites were analyzed manually with the fragmentor tool in ChemDraw (PerkinElmer, Waltham, MA) and with the molecular structure correlator function in MassHunter (i.e., all signals associated with a given analyte, with intensities >2000–5000, were used to profile metabolites at a 5-ppm mass accuracy threshold).
Tandem mass spectra were generated with an Agilent QTOF 6530 mass spectrometer to further confirm the identity of metabolites. For this analysis, the matched exact masses of parent and fragmented ions (<5 ppm mass error), and associated retention times (<20 seconds) were used to create a target list. Isotope patterns were also used to identify Cl-containing DCF metabolites.
+ Open protocol
+ Expand
5

Quantification of Ceramides and Sphingosine in Tracheal Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceramides and SPH in isolated tracheal epithelial cells were extracted and quantified as described (Fayyaz et al, 2014 (link)). Sample analysis was carried out by rapid-resolution liquid chromatography-MS/MS using a Q-TOF 6530 mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in the positive ESI mode. The precursor ions of SPH (m/z 300.289), C17-SPH (m/z 286.274), and ceramides (C16-ceramide (m/z 520.508), C17-ceramide (m/z 534.524), C18-ceramide (m/z 548.540), C18:1-ceramide (m/z 546.524), C20-ceramide (m/z 576.571), C22-ceramide (m/z 604.602), C24-ceramide (m/z 632.634), C24:1-ceramide (m/z 630.618)) were cleaved into the fragment ions of m/z 282.280, m/z 268.264, and m/z 264.270, respectively. Quantification was performed with Mass Hunter Software (Agilent Technologies).
+ Open protocol
+ Expand
6

LC-MS Fingerprinting of Herbal Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS analysis was carried out using an Agilent HPLC 1260 System, and an Agilent Q-TOF 6530 mass spectrometer was used as the detector for fingerprinting the extract. 1 mg of free dried sample extract was dissolved in 1 mL of methanol : water (50 : 50) by volume. The resulting mixture was transferred into a 5 mL syringe and filtered through a 0.22 μm acrosdisc syringe filter into an HPLC vial for LC-MS/MS analysis. Gradient elution with composition as follows: solvent A: (water with 0.1% formic acid), solvent B: acetonitrile with 0.1% formic acid, and injection volume: 5 μL. Column temperature was maintained at 40°C and with a total run time of 27 minutes. The LC-Q-TOF-MS data was analyzed using Agilent Technologies Mass Hunter Software Version B.07.03 (509).
+ Open protocol
+ Expand
7

NMR and Mass Spectrometry Analysis of Compound

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMR spectroscopic analysis were carried out at the Institute of Chemistry Potsdam, Germany. Samples F10b1 and F10b2 were dissolved in CD2Cl2 then 1D and 2D NMR spectra were recorded on a BRUKER AVANCE 500 spectrometer (Billerica, Massachusetts, USA). Residual solvent peaks of CD2Cl2 were used as a reference. Agilent HPLC 1260 System coupled to an Agilent Q-TOF 6530 Mass spectrometer was used to confirm the formula of the compound.
+ Open protocol
+ Expand
8

Quantitative Lipid Profiling of Platelets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Platelets were isolated as noted above and subjected to lipid extraction using 1.5 mL methanol/chloroform (2:1, v:v) as previously described (24 (link)). The extraction solvent contained d7sphingosine (d7-Sph), d7--sphingosine-1-phosphate (d7-S1P), C17-lysosphingomyelin (C17-LysoSM), C17-ceramide (C17-Cer) and C16-d31-sphingomyelin (C16-d31-SM) (all Avanti Polar Lipids, Alabaster, USA) as internal standards. Sample analysis was carried out by liquid chromatography tandem-mass spectrometry using either a TQ 6490 mass spectrometer for sphingosine (Sph), S1P, and lysosphingomyelin (LysoSM), or a QTOF 6530 mass spectrometer for ceramide and sphingomyelin species (both Agilent Technologies, Waldbronn, Germany) operating in the positive electrospray ionization mode. The following selected reaction monitoring transitions were used for quantification: m/z 300.3 → 282.3 for Sph, m/z 380.3 → 264.3 for S1P, m/z 465.4 → 184.1 for LysoSM, m/z 307.3 → 289.3 for d7-Sph, m/z 387.3 → 271.3 for d7-S1P and m/z 451.3 → 184.1 for C17-LysoSM. The precursor ions of ceramide or sphingomyelin species (differing in their fatty acid chain lengths) were cleaved into the fragment ions m/z 264.270 or m/z 184.074, respectively (25 (link)). Quantification was performed with Mass Hunter Software (Agilent Technologies).
+ Open protocol
+ Expand
9

Fecal Metabolomics Analysis by LC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LC–MS
analysis was performed as previously described with minor modifications.58 (link) Briefly, 20 mg fecal sample and 50 mg glass
beads (Sigma-Aldrich, MO) were added to 400 μL cooled methanol
solution (methanol/water, 1:1), followed by homogenization using a
TissueLyser (Qiagen, Hilden, Germany) at 50 Hz for 10 min. The supernatant
was collected after centrifuging for 10 min at 12 000 rpm,
followed by drying up in a speed vacuum (Thermo), and then resuspending
for injection. The mass spectrometer was interfaced with an Agilent
1290 Infinity II UPLC system. The LC–MS analysis was performed
on a quadrupole time-of-flight (Q-TOF) 6530 mass spectrometer (Agilent
Technologies, Santa Clara, CA) with an electrospray ionization source.
Metabolic features were analyzed in the positive mode over a m/z range of 50–1000 with a C18
T3 reverse-phased column (Waters Corporation, Milford, MA). The XCMS
Online sever (https://xcmsonline.scripps.edu, version 3.5.1) was applied for peak picking, alignment, integration,
and extraction of the peak intensities. MS/MS data were generated
on the Q-TOF for the identification of differentiated molecular features.
The software of MS-DIAL (version 2.90)59 (link) and MS-FINDER (version 2.40)60 (link) were used
for the identification of metabolites based on the MS/MS spectrum.
+ Open protocol
+ Expand
10

Quantification of Ceramides and Sphingomyelins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cer and SM were extracted and quantified as described previously (25 (link)). Briefly, lipid extraction was performed from 100 μl liver homogenates containing 50 μg total protein using C17:0-Cer and deuterated C16-d31 SM (N-palmitoyl-d31-D-erythro-sphingomyelin; Avanti Polar Lipids) as internal standards. Sample analysis was carried out by rapid-resolution liquid chromatography-MS/MS using a Q-TOF 6,530 mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in the positive ESI mode. The precursor ions of Cer species [C16:0-Cer (m/z 520.508), C17:0-Cer (m/z 534.524), C18:0-Cer (m/z 548.540), C20:0-Cer (m/z 576.571), C22:0-Cer (m/z 604.602), C24:0-Cer (m/z 632.634), C24:1-Cer (m/z 630.618)] were cleaved into the fragment ion m/z 264.270. The precursor ions of SM species [C16:0-SM (m/z 703.575), C16-d31 SM (m/z 734.762), C18:0-SM (m/z 731.606), C20:0-SM (m/z 759.638), C22:0-SM (m/z 787.669), C24:0-SM (m/z 815.700), C24:1-SM (m/z 813.684)] were cleaved into the fragment ion m/z 184.074. Quantification was performed with Mass Hunter Software (Agilent Technologies).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!